Background and Purpose
Codonopsis lanceolata (CL) has long been used as a medicinal herb
in East Asian countries to treat inflammatory diseases of the
respiratory system but its antiviral activity has not been investigated.
Here, we evaluated the potential inhibitory activity of CL extracts and
their active compounds on SARS-CoV-2.